Kodiak Sciences Inc (NASDAQ: KOD) Stock Information | RedChip

Kodiak Sciences Inc (NASDAQ: KOD) Listen to this Section


$2.48
-0.1100 ( -4.25% ) 124.2K

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Market Data


Open


$2.48

Previous close


$2.59

Volume


124.2K

Market cap


$129.96M

Day range


$2.47 - $2.62

52 week range


$1.37 - $7.77

Insider Ownership Transactions

Total Amount Purchased: -989,019.00 | $ -2,452,767.12

Date Type Amount Purchased Purchaser
2024-08-07 Sale -334500.00 BORGESON JOHN A.
2024-08-07 Sale -406000.00 PERLROTH VICTOR
2024-07-02 Sale -40000.00 BAKER BROS. ADVISORS LP
2024-07-01 Sale -40000.00 Bancroft Charles A
2024-07-01 Sale -40000.00 Dahiyat Bassil I
2024-07-01 Sale -40000.00 PROFUSEK ROBERT
2024-07-01 Sale -40000.00 Yang Taiyin
2024-07-01 Sale -40000.00 Levy Richard S
2024-06-18 Sale -5494.00 BORGESON JOHN A.
2024-06-13 Sale -3025.00 BORGESON JOHN A.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 12 Aug 14, 2024
10-q Quarterly Reports 40 Aug 14, 2024
4 Insider transactions 1 Aug 07, 2024
4 Insider transactions 1 Aug 07, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.